Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

COVID-19 infection: the perspectives on immune responses

Shi, Y., Wang, Y., Shao, C., Huang, J., Gan, J., Huang, X., Bucci, E. M., Piacentini, M., Ippolito, G., & Melino, G. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0530-3 · Cited by 1,602

Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic

(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537

Metformin improves healthspan and lifespan in mice

Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3192 · Cited by 1,445

COVID-19: Melatonin as a potential adjuvant treatment

Zhang, R., Wang, X., Ni, L., Di, X., Ma, B., Niu, S., Liu, C., & Reiter, R. J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117583 · Cited by 629

Relationship between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues

Burgos‐Morón, E., Abad‐Jiménez, Z., Marañón, A., Iannantuoni, F., Escribano‐López, I., López‐Domènech, S., Salom, C., Jover, A., Llabata, V. M., Torres, I. R., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091385 · Cited by 612

Reducing mortality from 2019-nCoV: host-directed therapies should be an option.

Zumla, A., Hui, D. S., Azhar, E. I., Memish, Z. A., & Maeurer, M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30305-6 · Cited by 429

Commentary: COVID-19 in patients with diabetes

Hill, M. A., Mantzoros, C. S., & Sowers, J. R. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154217 · Cited by 183

The Role of Metformin in Controlling Oxidative Stress in Muscle of Diabetic Rats

Vilela, D. D., Peixoto, L. G., Teixeira, R. R., Baptista, N. B., Caixeta, D. C., de Souza, A. V., Machado, H. L., Pereira, M. N., Silva, R. S., & Espíndola, F. S. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6978625 · Cited by 134

The kidnapping of mitochondrial function associated with the SARS-CoV-2 infection.

Soria‐Castro, E., Soto, M. E., Guarner‐Lans, V., Rojas, G., Pérezpeña-Díazconti, M., Críales-Vera, S., Pech, L. M., & Pérez-Torres, I. (2021) · PubMed · doi:10.14670/hh-18-354 · Cited by 26

Glycemic Control and Clinical Outcomes in U.S. Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database

Wong, R., Hall, M. D., Vaddavalli, R., Anand, A., Arora, N., Bramante, C. T., Garcia, V. L., Johnson, S., Saltz, M. M., Tronieri, J. S., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2186 · Cited by 26

Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes

Shao, S., Yang, Q., Pan, R., Yu, X., & Chen, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.731974 · Cited by 27

Demystifying pulmonary fibrosis

Jenkins, G. R. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00365.2020 · Cited by 23

Does Oxidative Stress Management Help Alleviation of COVID-19 Symptoms in Patients Experiencing Diabetes?

Paul, A. K., Hossain, M. K., Mahboob, T., Nissapatorn, V., Wilairatana, P., Jahan, R., Jannat, K., Bondhon, T. A., Hasan, A., Pereira, M. D. L., et al. (2022) · Nutrients · doi:10.3390/nu14020321 · Cited by 24

Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients

Lao, U.-S., Law, C.-F., Baptista‐Hon, D. T., & Tomlinson, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185454 · Cited by 24

Diabetes and COVID-19: The potential role of mTOR

Pinchera, B., Scotto, R., Buonomo, A. R., Zappulo, E., Stagnaro, F. M., Gallicchio, A., Viceconte, G., Sardanelli, A., Mercinelli, S., Villari, R., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109813 · Cited by 23

The role of T‐cell immunity in COVID‐19 severity amongst people living with type II diabetes

Tong, Z. W. M., Grant, E. J., Gras, S., Wu, M., Smith, C., Barrett, H. L., Gallo, L. A., & Short, K. R. (2021) · FEBS Journal · doi:10.1111/febs.16105 · Cited by 23

Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection

Bielka, W., Przezak, A., & Pawlik, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147605 · Cited by 23

Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis

Ma, Z., & Krishnamurthy, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282210 · Cited by 21

Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients

Hasan, S. S., Kow, C. S., Bain, A., Kavanagh, S., Merchant, H. A., & Hadi, M. A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1837114 · Cited by 23

Association Between Metformin Use and Mortality Among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection

Ong, A. N., Tan, C. C., Cañete, M. T. A., Lim, B. A., & Robles, J. (2021) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.036.02.20 · Cited by 20

Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes

Usman, A., Bliden, K. P., Cho, A., Walia, N., Jerjian, C., Singh, A., Kundan, P., Duhan, S., Tantry, U. S., & Gurbel, P. A. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02631-7 · Cited by 20

Design, structural characterization, DFT, molecular docking, and chemotherapeutic activity of novel platinum(II) and palladium(II) complexes derived from Metformin-based Schiff base

Hassan, S. S., Mohamed, E. F., Saleh, A. M., Shoukry, M. M., & Khalf‐Alla, P. A. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138830 · Cited by 19

Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review

Plowman, T. J., Christensen, H., Aiges, M., Fernandez, E., Shah, M. H., & Ramana, K. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105190 · Cited by 20

Vascular Events, Vascular Disease and Vascular Risk Factors—Strongly Intertwined with COVID-19

Scutelnic, A., & Heldner, M. R. (2020) · Current Treatment Options in Neurology · doi:10.1007/s11940-020-00648-y · Cited by 19

Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid

Jiang, Y., Yan, Q., Liu, C., Peng, C.-W., Zheng, W., Zhuang, H., Huang, H.-T., Liu, Q., Liao, H., Zhan, S., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105601 · Cited by 19

A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19

Mashayekhi‐Sardoo, H., & Hosseinjani, H. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0495 · Cited by 17

Drug-Based Therapeutic Strategies for COVID-19-Infected Patients and Their Challenges

Zarkesh, K., Entezar-Almahdi, E., Ghasemiyeh, P., Akbarian, M., Bahmani, M., Roudaki, S., Fazlinejad, R., Mohammadi‐Samani, S., Firouzabadi, N., Hosseini, M., et al. (2021) · Future Microbiology · doi:10.2217/fmb-2021-0116 · Cited by 18

Is diabetes mellitus a wrongdoer to COVID-19 severity?

Sarkar, S., Das, D., Wann, S. B., Kalita, J., & Manna, P. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108936 · Cited by 17

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review

Popovic, D. S., Παπάνας, Ν., Stoian, A. P., Rizvi, A. A., Janež, A., & Rizzo, M. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01170-3 · Cited by 18

Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID ‐19: A systematic review and meta‐analysis

Nassar, M., Abosheaishaa, H. M., Singh, A. K., Misra, A., & Bloomgarden, Z. T. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13359 · Cited by 17

Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism

Poly, T. N., Islam, M. M., Li, Y., Lin, M., Hsu, M., & Wang, Y. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163507 · Cited by 18

Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection

Alabsi, S. M., Dhole, A., Hozayen, S. M., & Chapman, S. A. (2023) · Microorganisms · doi:10.3390/microorganisms11030612 · Cited by 16

Acute Kidney Injury in Hospitalized Patients with COVID-19: Risk Factors and Serum Biomarkers

Shchepalina, A. A., Chebotareva, N. V., Анатольевна, А. Л., Brovko, M., Sholomova, V. I., Androsova, T. V., Korotchaeva, Y. V., Kalmykova, D. Y., Tanaschuk, E. L., Taranova, M. V., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11051246 · Cited by 16

How anti-ageing drugs could boost COVID vaccines in older people

Willyard, C. (2020) · Nature · doi:10.1038/d41586-020-02856-7 · Cited by 16

Peculiarities of the COVID-19 course and consequences in overweight and obese patients. Lessons from the current pandemic

Demidova, T. Y., Volkova, E., & Gritskevich, Е. Y. (2020) · Obesity and metabolism · doi:10.14341/omet12663 · Cited by 16

COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies

Hua, S., Yang, Y., Zou, D., Li, J., Yan, K., Xu, Y., Jiang, X. X., Rong, X., & Ye, D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111685 · Cited by 16

Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529)

Yonekawa, A., & Shimono, N. (2022) · Biology · doi:10.3390/biology11030400 · Cited by 18

The Mycophenolate-based Immunosuppressive Regimen Is Associated With Increased Mortality in Kidney Transplant Patients With COVID-19

Requião‐Moura, L., de Andrade, L. G. M., de Sandes‐Freitas, T. V., Cristelli, M. P., Viana, L. A., Nakamura, M. R., Garcı́a, V. D., Manfro, R. C., Simão, D. R., Almeida, R. A. M. D. B., et al. (2022) · Transplantation · doi:10.1097/tp.0000000000004251 · Cited by 16

Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period

Saygılı, E. S., Karakılıç, E., Mert, E., Şener, A., & Mirci, A. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02823-9 · Cited by 15

Host Genetic Liability for Severe COVID-19 Associates with Alcohol Drinking Behavior and Diabetic Outcomes in Participants of European Descent

Wendt, F. R., Lillo, A. D., Pathak, G. A., Angelis, F. D., Initiative, C.-1. H. G., & Polimanti, R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.765247 · Cited by 15

Reduced Mortality With Ondansetron Use in SARS-CoV-2-Infected Inpatients

Bayat, V., Ryono, R. A., Phelps, S., Geis, E., Sedghi, F., Etminani, P., & Holodniy, M. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab336 · Cited by 14

Metformin: an inexpensive and effective treatment in people with diabetes and COVID-19?

Dardano, A., & Prato, S. D. (2020) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(20)30047-7 · Cited by 14

One hundred years since insulin discovery: An update on current and future perspectives for pharmacotherapy of diabetes mellitus

Seetharaman, R., Pawar, S. R., & Advani, M. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15100 · Cited by 17

Effects of metformin on changes of miR-19a and miR-221 expression associated with myocardial infarction in patients with type 2 diabetes

Mansouri, F., & Seyed-Mohammadzad, M. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102602 · Cited by 14

The central role of neutrophil extracellular traps (NETs) and by‐products in COVID‐19 related pulmonary thrombosis

Li, S., Wang, H., & Shao, Q. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.949 · Cited by 14

Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment

Chawla, U., Kashyap, M. K., & Husain, A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04200-7 · Cited by 14

Metformin in SARS-CoV-2 infection: A hidden path – from altered inflammation to reduced mortality. A review from the literature

Pedrosa, A. R., Martins, D. C., Rizzo, M., & Silva‐Nunes, J. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108391 · Cited by 13

Senotherapeutics: An emerging approach to the treatment of viral infectious diseases in the elderly

Li, Z., Tian, M., Wang, G., Cui, X., Ma, J., Liu, S., Shen, B., Liu, F., Wu, K., Xiao, X., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1098712 · Cited by 13

Metformin in acute respiratory distress syndrome: An opinion

Uddin, M. A., Akhter, M. S., Kubra, K., Siejka, A., & Barabutis, N. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111197 · Cited by 12

Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans

Hunt, C. M., Efird, J. T., Redding, T. S., Thompson, A. D., Press, A. M., Williams, C. D., Hostler, C. J., & Suzuki, A. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07701-3 · Cited by 12

Exploring cutting-edge approaches in diabetes care: from nanotechnology to personalized therapeutics

Asaad, G. F., Doghish, A. S., Rashad, A. A., & El‐Dakroury, W. A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03532-7 · Cited by 12

Metainflammation in COVID-19

Bakhtiari, M., & Asadipooya, K. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220104103325 · Cited by 11

New-onset diabetes in COVID-19: The molecular pathogenesis

Wihandani, D. M., Purwanta, M. L. A., Mulyani, W. R. W., Putra, I. W. A. S., & Supadmanaba, I. G. P. (2023) · Biomedicine · doi:10.37796/2211-8039.1389 · Cited by 14

Therapeutic approaches and vaccination in fighting COVID-19 infections: A review

Adibzadeh, S., Amiri, S., Nia, G. E., Taleghani, M. R., Bijarpas, Z. K., Maserat, N., Maali, A., Azad, M., & Behzad‐Behbahani, A. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101619 · Cited by 10

Metformin as a potential treatment for COVID-19

McCarthy, M. W. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2215385 · Cited by 11

Strict glycemic control is needed in times of COVID19 epidemic in India: A Call for action for all physicians

Aravind, S. R., Saboo, B., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.08.003 · Cited by 10

Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India

Gupta, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.009 · Cited by 10

Metformin-associated lactic acidosis and acute kidney injury in the era of COVID-19

Vordoni, A., Theofilis, P., Vlachopanos, G., Koukoulaki, M., & Kalaitzidis, R. (2021) · Frontiers in Bioscience-Scholar · doi:10.52586/s563 · Cited by 10

Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19

Yang, S., Tong, Y., Chen, L., & Yu, W. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00077-0 · Cited by 10

Metformin treatment of the C9orf72 ALS/FTD mouse: Almost too good for words

Rosbash, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012363117 · Cited by 9

Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic

Jerzak, M. M., & Szafarowska, M. (2022) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-022-00650-z · Cited by 9

Gene set proximity analysis: expanding gene set enrichment analysis through learned geometric embeddings, with drug-repurposing applications in COVID-19

Cousins, H. C., Hall, T. O., Guo, Y., Tso, L., Tzeng, K., Cong, L., & Altman, R. B. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac735 · Cited by 8

Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19

Futatsugi, H., Iwabu, M., Okada‐Iwabu, M., Okamoto, K., Amano, Y., Morizaki, Y., Kadowaki, T., & Yamauchi, T. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.593061 · Cited by 9

Metformin as a Therapeutic Agent for Obesity-Associated Immune Dysfunction

Rajeev, D., & MacIver, N. J. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.07.001 · Cited by 10

Poor glycemic control in type‐2 diabetic patients infected with hepatitis B: A retrospective propensity‐matched study

Cai, T., Yue, T., Xu, M., Zhang, P., Wang, Y., Liu, Q., Huang, J. M., Shen, T., Yin, Q., Sheng, Z., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28635 · Cited by 8

Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic

Gonikman, D., & Kustovs, D. (2023) · Medicina · doi:10.3390/medicina59101810 · Cited by 10

Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients

Leowattana, W. (2021) · World Journal of Virology · doi:10.5501/wjv.v10.i3.86 · Cited by 8

A metabolic blueprint of COVID-19 and long-term vaccine efficacy

Berber, E., Sumbria, D., & Kökkaya, S. (2022) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2022-0148 · Cited by 8

Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study

Bramante, C. T., Johnson, S., Garcia, V. L., Evans, M. D., Harper, J. R., Wilkins, K. J., Huling, J. D., Mehta, H. B., Alexander, C., Tronieri, J. S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271574 · Cited by 8

What Every Diabetologist Should Know about SARS-CoV-2: State of Knowledge at the Beginning of 2021

Abramczyk, U., & Kuzan, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051022 · Cited by 8

Targeting T cell (oxidative) metabolism to improve immunity to viral infection in the context of obesity

Greene, E., & MacIver, N. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1025495 · Cited by 9

Association of the patterns of use of medications with mortality of COVID-19 infection: a hospital-based observational study

Wallace, A. W., Cirillo, P. M., Ryan, J. C., Krigbaum, N. Y., Badathala, A., & Cohn, B. A. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050051 · Cited by 7

Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort

Wong, C. K. H., Lui, D. T. W., Lui, A. Y. C., Low, M. C. H., Kwok, A. C. Y., Lau, K. T. K., Au, I. C. H., Xiong, X., Chung, M. S. H., Lau, E. H. Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.810914 · Cited by 7

The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases

Szilveszter, M., Pál, S., Simon-Szabó, Z., Akácsos-Szász, O.-Z., Moldován, M., Réger, B., Dénes, L., Faust, Z., Tilinca, M. C., & Nemes-Nagy, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612782 · Cited by 7

The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies

Song, Z., Huang, Q.-M., Xu, S.-S., Zhou, J.-B., & Zhang, C. (2024) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-024-00633-6 · Cited by 7

Prevention and Management of Type 2 Diabetes and Metabolic Syndrome in the Time of COVID-19: Should We Add a Cup of Coffee?

Semiz, S., & Serdarević, F. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.581680 · Cited by 8

Is metformin a miracle or a menace in COVID‐19 patients with type 2 diabetes?

Lui, D. T. W., & Tan, K. C. B. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13484 · Cited by 7

The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course—A Narrative Review

Tzeravini, E., Stratigakos, E., Siafarikas, C., Tentolouris, A., & Tentolouris, N. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.812134 · Cited by 6

The prevention and treatment of COVID-19 in patients treated with hemodialysis

Zeng, B., Zhou, J., Peng, D., Dong, C., & Qin, Q. (2023) · European journal of medical research · doi:10.1186/s40001-023-01389-9 · Cited by 8

Glycaemic Characteristics and Outcomes of COVID-19 Patients Admitted to a Tertiary Hospital in Johannesburg

Mohamed, F., Raal, F. J., Mbelle, M., Zamparini, J. M., Venturas, J., Shaddock, E. J., Diana, N. E., Mer, M., Dingezweni, S., Bolon, S., et al. (2020) · Wits Journal of Clinical Medicine · doi:10.18772/26180197.2020.v2n3a1 · Cited by 7

Metformin therapy and severity and mortality of SARS-CoV-2 infection: a meta-analysis

Oscanoa, T. J., Amado, J., Vidal, X., Savarino, A., & Romero‐Ortuño, R. (2021) · Clinical Diabetology · doi:10.5603/dk.a2021.0035 · Cited by 6

Repurposing pharmaceutical excipients as an antiviral agent against SARS-CoV-2

Malani, M., Salunke, P. M., Kulkarni, S., Jain, G., Sheikh, A., Kesharwani, P., & Nirmal, J. (2021) · Journal of Biomaterials Science. Polymer Edition · doi:10.1080/09205063.2021.1975020 · Cited by 5

Pediatric endocrinopathies related to COVID-19: an update

Memar, E. H. E., Mohsenipour, R., Sadrosadat, S. T., & Rostami, P. (2022) · World Journal of Pediatrics · doi:10.1007/s12519-022-00662-x · Cited by 5

Integrative Analysis of Functional Genomic Screening and Clinical Data Identifies a Protective Role for Spironolactone in Severe COVID-19

Cousins, H. C., Kline, A. S., Wang, C., Qu, Y., Zengel, J. R., Carette, J. E., Wang, M., Altman, R. B., Luo, Y., & Cong, L. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100503 · Cited by 5

Intrinsic Factors Behind the Long‐COVID: V. Immunometabolic Disorders

Adilović, M., Hromić‐Jahjefendić, A., Mahmutović, L., Šutković, J., Rubio‐Casillas, A., Redwan, E. M. M. M., & Uversky, V. N. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30683 · Cited by 5

Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review

Berlie, H. D., Kale-Pradhan, P. B., Orzechowski, T., & Jaber, L. A. (2021) · Annals of Pharmacotherapy · doi:10.1177/1060028021999473 · Cited by 5

Clinical course and disease outcomes in hospitalized patients with 2019 novel corona virus disease at Ibn- Al Khateeb Hospital in Baghdad, Iraq

Mohammed, I. A., Ali, A. H., & shenaty, J. N. A. (2020) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/jfacmedbagdad.6231775 · Cited by 5

Molecular mechanisms and signaling pathways involved in immunopathological events of COVID-19

Peyvandi, A. A., Niknazar, S., Mehrjerdi, F. Z., Abbaszadeh, H., Khoshsirat, S., & Peyvandi, M. (2021) · Physiology and Pharmacology · doi:10.52547/ppj.25.3.193 · Cited by 5

Genetic and Phenotypic Evidence for the Causal Relationship Between Aging and COVID-19Preprint

Ying, K., Zhai, R., Pyrkov, T. V., Mariotti, M., Fedichev, P. O., Shen, X., & Gladyshev, V. N. (2020) · medRxiv · doi:10.1101/2020.08.06.20169854 · Cited by 5

Metformin use associated with lower rate of hospitalization for influenza in individuals with diabetes

Greene, E., Green, C. L., Hurst, J. H., & MacIver, N. J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15655 · Cited by 4

SARS-CoV-2 spike protein causes synaptic dysfunction and p-tau and α-synuclein aggregation leading cognitive impairment: The protective role of metformin

Lee, H. J., Choi, J. Y., Park, J. H., Chang, M. H., Park, J. H., & Koh, Y. H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336015 · Cited by 4

Clinical Features and Changes in Insulin Requirements in People with Type 2 Diabetes Requiring Insulin When Hospitalised with SARS-CoV-2 Infection

Corcillo, A., Saqib, A., Sithamparanathan, N., Khanam, A., Williams, J., Gulati, A., Kariyawasam, D., & Karalliedde, J. J. (2022) · International Journal of Endocrinology · doi:10.1155/2022/8030765 · Cited by 4

AMP kinase: A promising therapeutic drug target for post-COVID-19 complications

Ashraf, M. S., Tuli, K., Moiz, S., Sharma, S. K., Sharma, D., & Adnan, M. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123202 · Cited by 4

Antidiabetic agent use and clinical outcomes in patients with diabetes hospitalized for COVID-19: a systematic review and meta-analysis

Keels, J. N., McDonald, I. R., Lee, C. S., & Dwyer, A. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1482853 · Cited by 4

IMPACT OF ANTIDIABETIC DRUGS ON RISK AND OUTCOME OF COVID-19 INFECTION: A REVIEW

Zainal, A. A., & Merkhan, M. M. (2022) · Military Medical Science Letters · doi:10.31482/mmsl.2022.004 · Cited by 6

Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health care in Catalonia during the first wave of the pandemic

Ouchi, D., Vilaplana-Carnerero, C., de Dios, V., Giner‐Soriano, M., & Morros, R. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.10.001 · Cited by 4

Effectiveness of early treatment of lopinavir–ritonavir in patients with severe COVID-19: a case series

Luo, P., Zheng, J., Liu, Y., Qiu, L., Liu, X., Xue, H., Liu, D., & Li, J. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0348 · Cited by 4

COVID‐19 and varicocele: The possible overlap factors and the common therapeutic approaches

Mahdavinezhad, F., Farmani, A. R., Pakniat, H., Taghavi, S., Gharaei, R., Valipour, J., & Amidi, F. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13518 · Cited by 4

Gerociencia en tiempos de pandemia global por COVID-19

Castro-Fuentes, R., Castro‐Hernández, J., & Socas-Pérez, R. (2021) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2021.08.001 · Cited by 4

Possible Therapeutic Targets from Derivatives of Natural Marine Products Based on PI3K/AKT Dependent Inhibitors in Viral Infection COVID-19

Aleebrahim‐Dehkordi, E. (2022) · Cellular Physiology and Biochemistry · doi:10.33594/000000595 · Cited by 2

Metformin use and its association with various outcomes in COVID-19 patients with diabetes mellitus: a retrospective cohort study in a tertiary care facility

Somasundaram, M., Mathew, S. K., Paul, S., Kurian, S. J., Kunhikatta, V., Karanth, S., Shetty, S., Kudru, C. U., Manu, M. K., Saravu, K., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2425829 · Cited by 3

Сахарный диабет у пожилых пациентов в условиях новой коронавирусной инфекции (COVID-19) .

Mustafina, S. V., & Каширина, А. П. (2022) · Russian Journal of Geriatric Medicine · doi:10.37586/2686-8636-4-2021-414-419 · Cited by 3

Covid-19 and endocrinology – intersections: a review of current knowledge on physiopathological associations

dos Santos, L. R., Filho, R. B., Alves, T. A. F. D. A., Jardine, M. B., & Duarte, M. L. (2020) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2020.08.00286 · Cited by 3

Immunometabolism and Covid-19: Could Lifelong Exercise Training Have a Protective Effect?

Minuzzi, L. G., Teixeira, A. M., dos Santos, R. V. T., Neto, J. C. R., & Lira, F. S. (2020) · Immunometabolism · doi:10.20900/immunometab20210001 · Cited by 4

Drug Repositioning Using Multiplex-Heterogeneous Network Embedding: A Case Study on SARS-CoV2

Pio‐Lopez, L. (2022) · Studies in computational intelligence · doi:10.1007/978-3-030-93413-2_60 · Cited by 3

Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study

Miao, E., Zhang, K., Liu, J., Lin, J., Yoo, D. A., & George, C. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1002834 · Cited by 3

Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms

Brock, S., Jackson, D., Soldatos, T. G., Hornischer, K., Schäfer, A., Diella, F., Emmert, M. Y., & Hoerstrup, S. P. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.1035290 · Cited by 3

Potential Drugs in COVID-19 Management

Gasmi, A., Noor, S., Menzel, A., Khanyk, N., Semenova, Y., Lysiuk, R., Beley, N. M., Bolibrukh, L., Benahmed, A. G., Storchylo, O. V., et al. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230717154101 · Cited by 3

Metformin use and its association with various outcomes in COVID-19 patients with diabetes mellitus: a retrospective cohort study in a tertiary care facility

Somasundaram, M., Mathew, S. K., Paul, S., Kurian, S. J., Kunhikatta, V., Karanth, S., Shetty, S., Kudru, C. U., Manu, M. K., Saravu, K., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2425829 · Cited by 3

Metformin significantly lowers the mortality rate in diabetic COVID-19 patientsPreprint

Korkusuz, R., Karandere, F., Okay, F., & Koçoğlu, H. (2021) · Research Square · doi:10.21203/rs.3.rs-1182263/v1 · Cited by 1

Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID ‐19 patients with diabetes: A population‐based study in Lombardy

Fernandez, M. L. O., Foresta, A., Macaluso, G., Colacioppo, P., Tettamanti, M., Zambon, A., Genovese, S., Fortino, I., Leoni, O., Roncaglioni, M. C., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14648 · Cited by 25

Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection

Hariyanto, T. I., & Kurniawan, A. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100290 · Cited by 132

Covid-19 in Hospitalized Patients with Type 2 Diabetes Treated by Metformin: A Systemic Review and Retrospective Analysis

Jankovsky, M., Jackuliak, P., Nachtmann, S., Smaha, J., & Payer, J. (2025) · Journal of Medicine and HealthCare · doi:10.47363/jmhc/2025(7)311